This message contains images. If you don't see images, click here to view.
Advertise in this news brief.




  Mobile version    RSS    Subscribe    Unsubscribe    Archive    Media Kit           Sep. 25, 2013

Home     About SGO    Education    Membership    Clinical Practice    Public Policy    Blog    Partnerships    Store

 

Weight bias in cancer care? Obese cancer patients often shorted on chemo, hurting survival
The Associated Press via The Washington Post
Obese people are less likely to survive cancer, and one reason may be a surprising inequality: The overweight are undertreated. Doctors often short them on chemotherapy by not basing the dose on size, as they should. They use ideal weight or cap the dose out of fear about how much treatment an obese patient can bear. Yet research shows that bigger people handle chemo better than smaller people do.
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE  




TREATMENT


Cisplatin combined with high-dose brachytherapy for advanced cervical cancer may be more beneficial
Science Codex
Adding the chemotherapy drug cisplatin to a treatment plan of radiation therapy and high-dose-rate brachytherapy for stage IIIB cervical cancer is beneficial, according to research presented today at the American Society for Radiation Oncology's 55th Annual Meeting. The study also indicated that the combined treatments produced acceptable levels of toxicity.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Simple, 2-question survey accurately screens cancer patients for depression
Medical Xpress
Cancer patients can be accurately screened for major depression with a simple two-question survey, according to a study presented at the American Society for Radiation Oncology's 55th Annual Meeting. The two-question screening test proved to be as accurate as a longer nine-question screening test. The study was presented at plenary session by William Small, Jr., MD, FASTRO, chair of the Department of Radiation Oncology of Loyola University Medical Center.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Advertisement
PRODUCT SHOWCASE
  A Medical ‘Must Have’

Morrow’s Gynecologic Cancer Surgery, 2nd Edition is an invaluable comprehensive surgical text book resource containing step-by-step written and illustrated descriptions of all the important operations in the field of gynecologic oncology.The book contains 1044 pages with more than 300 illustrations and 150 photographs to complement the step by step description of every operative procedure.
 


The best cancer care isn't always the most expensive
The Washington Post
On Sept. 10, the Institute of Medicine released a new report, "Delivering high-quality cancer care: charting a new course for a system in crisis." Like many IOM publications, this report makes for depressing reading, not because it contains dramatic or frightening revelations, but because many of its recommendations are so obvious and yet would be so difficult to execute in our high-tech but unwieldy, costly and fragmented healthcare delivery system.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


PREVENTION


Panel: Discuss cancer-reducing meds with at-risk women
Reuters
Doctors should talk with women who are at higher-than-average risk of breast cancer about medications that would reduce that risk so they can make informed decisions, a government-backed panel said. Those drugs, tamoxifen and raloxifene, block the effects of estrogen in breast tissue. But they can come with side effects such as hot flashes and increase women's risk of blood clots.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


RESEARCH


Study: Married cancer patients are more likely to survive
USA Today
Scientists say they may have found the key to surviving cancer: marriage. Married people with cancer were 20% less likely to die from their disease, compared to people who are separated, divorced, widowed or never married, according to study published online in the Journal of Clinical Oncology.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Prima Biomed's ovarian cancer treatment shows no difference in study
The Wall Street Journal
Prima Biomed Ltd.'s investigational vaccine therapy to treat a type of ovarian cancer showed no observed difference when compared with results in a control arm in an early-stage study, resulting in the Australian company temporarily suspending enrollment in another study.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Study: Mucus protects uterine and pancreatic cancer cells
UPI
A "vicious cycle" produces mucus that protects uterine and pancreatic cancer cells and promotes their proliferation, U.S. researchers say. Biochemist Daniel Carson, dean of Rice University's Wiess School of Natural Sciences; lead author Neeraja Dharmaraj, a postdoctoral researcher; and graduate student Brian Engel found that protein receptors on the surface of cancer cells go into overdrive to stimulate the production of MUC1, a glycoprotein that forms mucin, or mucus.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


 



Women's Cancer News
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Caitlin McNeely, Content Editor, 469.420.2692  
Contribute news


Inclusion of advertisements does not constitute SGO endorsement of company products or services.

Be sure to add us to your address book or safe sender list so our emails get to your inbox. Learn how.

This edition of the Women's Cancer News was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!

Recent issues

Sept. 18, 2013
Sept. 11, 2013
Sept. 4, 2013
2013-09-04






7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063